EGFR and non-small cell lung carcinoma: EGFR ex20ins is the third most common subtype of EGFR mutations, occurring in 0.1%–4.0% of all NSCLC cases and representing 4%–12% of patients with EGFR mutations (Oxnard et al., 2013; Burnett et al., 2021).